ArticleCancer cell international2021

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma.

Mingming Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.